Atomera (NASDAQ:ATOM) Announces Quarterly Earnings Results, Misses Expectations By $0.04 EPS

Atomera (NASDAQ:ATOM) released its quarterly earnings data on Tuesday. The technology company reported ($0.17) EPS for the quarter, missing the consensus estimate of ($0.13) by ($0.04), Zacks reports. The company had revenue of $0.01 million during the quarter, compared to the consensus estimate of $0.08 million.

Here are the key takeaways from Atomera’s conference call:

• Measured silicon results show MST outperforms an industry-standard approach for a critical Gate-All-Around source/drain liner; Atomera is running wafer demonstrations with two target customers (deposition turnaround 2–3 months, electrical results potentially ~6 months) supported by an expanded strategic partner relationship.
• Atomera reported a GaN-on-Silicon breakthrough — preliminary data indicate MST dramatically reduces the parasitic channel in RF GaN, which could accelerate adoption in RF and power markets and is being validated with ecosystem partners (Synopsys, research labs, test partners).
• The company says its pipeline is active across advanced logic, memory (DRAM/HBM), RF SOI, and power devices with multiple IDM and foundry engagements (including STMicro and a large unnamed IDM), but converting technical validation into license/JDA agreements remains timing-uncertain.
• Q1 results showed a GAAP net loss of $6.1M (non‑GAAP loss $4.9M) and minimal revenue ($11k); Atomera raised $25M in a February registered direct offering (cash + short-term investments $41.1M) to fund operations, which reduces near-term funding risk but involves dilution and ongoing operating expense guidance of about $18.5M for 2026.

Atomera Stock Up 1.8%

Shares of NASDAQ:ATOM opened at $10.56 on Wednesday. The stock has a market capitalization of $408.88 million, a PE ratio of -16.25 and a beta of 2.00. The firm’s 50 day moving average price is $5.26 and its 200-day moving average price is $3.66. Atomera has a twelve month low of $1.89 and a twelve month high of $11.48.

Institutional Trading of Atomera

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Geode Capital Management LLC boosted its stake in shares of Atomera by 98.3% during the 2nd quarter. Geode Capital Management LLC now owns 719,509 shares of the technology company’s stock worth $3,627,000 after acquiring an additional 356,579 shares during the last quarter. Marshall Wace LLP bought a new position in Atomera in the 4th quarter worth $396,000. Jane Street Group LLC lifted its position in Atomera by 243.1% during the fourth quarter. Jane Street Group LLC now owns 171,424 shares of the technology company’s stock valued at $379,000 after purchasing an additional 121,457 shares in the last quarter. XTX Topco Ltd purchased a new position in Atomera during the fourth quarter valued at $213,000. Finally, Goldman Sachs Group Inc. grew its holdings in Atomera by 82.3% during the first quarter. Goldman Sachs Group Inc. now owns 140,254 shares of the technology company’s stock valued at $561,000 after purchasing an additional 63,305 shares during the period. 30.79% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Separately, Wall Street Zen raised shares of Atomera from a “sell” rating to a “hold” rating in a report on Saturday, February 28th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Atomera has an average rating of “Sell”.

About Atomera

Atomera Inc is a materials engineering company that develops and licenses advanced thin film technologies for the semiconductor industry. Its flagship offering, Mears Silicon Technology (MST), is designed to enhance transistor performance, improve power efficiency and boost device yields. Atomera’s solutions are integrated into existing fabrication processes without major changes to equipment or materials flows, enabling foundries and integrated device manufacturers to adopt the technology with minimal disruption.

At the core of Atomera’s business model is the licensing and patent-licensing of MST.